Skip to content

Evaluation of the effects of ginger consumption on eradication of H.pylori, clinical symptoms, inflammatory factors, and oxidative stress in patients with peptic ulcer

Evaluation of the effects of ginger consumption on eradication of H.pylori, clinical symptoms, inflammatory factors, and oxidative stress in patients with peptic ulcer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100524004010N35
Enrollment
42
Registered
2023-02-08
Start date
2023-02-08
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer. Peptic ulcer, site unspecified

Interventions

Intervention 1: Intervention group: will take 2g of ginger daily in the form of four tablets each contains 500 mg of ginger (Product of Dine Company) orally for six weeks. Intervention 2: Control grou

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: General desire to practice the study Age over 18 years and less than 80 years Confirmation of H. pylori infection by stool antigen test or endoscopic pathology findings No antibiotic use in the last 4 weeks No active alcohol consumption or alcohol, corticosteroid and anticoagulant use No diseases Cardiovascular, liver, lung, kidney, malignancy Absence of recent surgery Absence of pregnancy or breastfeeding in women Absence of allergy to H pylori infection eradication regimen

Exclusion criteria

Exclusion criteria: Unwilling to continue the study Any allergic reaction to the supplements Consumption of less than 90% of supplements at the end of the study period

Design outcomes

Primary

MeasureTime frame
H.Pylori eradication. Timepoint: 8 week. Method of measurement: Endoscopy and Pathology.;Clinical Symptoms. Timepoint: 8 week. Method of measurement: Questionnaire.;Anti-oxidant status. Timepoint: 8 week. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzita Hekmatdoost

Shahid Beheshti University of Medical Sciences

a_hekmat2000@yahoo.com+98 21 2235 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026